CEO of Tylenol Manufacturer Addresses Autism Concerns in Meeting with RFK Jr.
September 12, 2025 - 20:35
In a recent private meeting, the interim CEO and director of Kenvue, the company behind the popular pain reliever Tylenol, engaged in discussions with U.S. Health and Human Services Secretary Robert F. Kennedy Jr. The meeting aimed to address concerns regarding the potential association between the medication and autism. The CEO emphasized that scientific research has not established any clear link between the use of Tylenol and the development of autism spectrum disorders.
The dialogue comes amidst rising scrutiny and ongoing debates surrounding the safety of various medications during pregnancy and early childhood. The CEO's efforts appear to be focused on preventing the inclusion of Tylenol in a forthcoming report that could suggest a connection to autism, a point of contention that has garnered significant public interest and concern.
Both parties acknowledged the importance of continuing to review and analyze existing research to ensure public safety while addressing the anxieties of parents and caregivers.
MORE NEWS
April 10, 2026 - 17:46
Wearables need to cross from consumer to health care marketThe wearable technology market stands at a pivotal juncture. Industry analysts warn that devices like smartwatches and fitness trackers risk following a well-worn path if they fail to successfully...
April 10, 2026 - 01:14
Nevada Health Centers’ Mammovan expands rural mammograms, seeks licensed driversFor women across Nevada, getting an annual mammogram can be quicker and more convenient thanks to a mobile clinic designed to bring breast cancer screenings directly to underserved communities. The...
April 9, 2026 - 00:55
SGMC Health Honors Lane with Safe Care AwardSGMC Health has presented its Safe Care Award to Peter Lane, a certified clinical perfusionist, in recognition of his outstanding dedication to patient safety and clinical excellence. Lane was...
April 8, 2026 - 15:44
Baton Rouge General's Health Tip of the Week: What to know about new cholesterol guidelinesHeart health is getting a head start, with updated medical recommendations now advising that your 30s are the time to begin proactive monitoring. The new guidelines call for annual cholesterol...